| 产品名称: | Phenylobacterium immobile |
|---|---|
| 商品货号: | TS261297 |
| <strong>Name </strong>: | Phenylobacterium immobile Lingens et al. 1985 |
| <strong>DSM No. </strong>: | 1986, Type strain dsm-1986 dsm1986 dsm 1986 Phenylobacterium immobile |
| Strain designation : | E |
| Other collection no. <br />or WDCM no. : | ATCC 35973, NCIB 12055 |
| Isolated from : | soil, enrichment with chloridazon |
| Country : | Ecuador |
| Date of sampling : | before 09.12.1980 |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Cultivation conditions : | Medium 363 (for reactivation, incubate lyophilised cells in liquid medium for up to 14 days), 28°C or Medium 464 (diluted 1:3), 28°C Complete DSMZ Media List |
| Summary and <br />additional information : | Type strain. Taxonomy/description (2944, 2955). Plasmids (2957). Produces catechol-2,3-dioxygenase (2949), pyrazon dioxygenase (2948), dihydrodiols from phenylalanine (2951), 2-keto-4-hydroxy valeric acid (2950). Utilizes antipyrin (analgetic) (2947), chloridazon (2944), trans-cinnamic acid (2956). Composition of lipopolysaccharide (2952). Rhodanese activity (2953). Serological studies (2954). (Medium 363 (for reactivation, incubate lyophilised cells in liquid medium for up to 14 days) or medium 464 (diluted 1:3), 28°C). |
| For detailed information : | BacDive - The Bacterial Diversity Metadatabase |
| Literature : | 2944, 2945, 2946, 2947, 2948, 2949, 2950, 2951, 2952, 2953, 2954, 2955, 2956, 2957 |
| Risk group : | 1 (classification according to German TRBA) |
| Other cultures : | All DSMZ cultures of the species |
| 产品名称: | Phenylobacterium immobile |
|---|---|
| 商品货号: | TS261297 |
| <strong>Name </strong>: | Phenylobacterium immobile Lingens et al. 1985 |
| <strong>DSM No. </strong>: | 1986, Type strain dsm-1986 dsm1986 dsm 1986 Phenylobacterium immobile |
| Strain designation : | E |
| Other collection no. <br />or WDCM no. : | ATCC 35973, NCIB 12055 |
| Isolated from : | soil, enrichment with chloridazon |
| Country : | Ecuador |
| Date of sampling : | before 09.12.1980 |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Cultivation conditions : | Medium 363 (for reactivation, incubate lyophilised cells in liquid medium for up to 14 days), 28°C or Medium 464 (diluted 1:3), 28°C Complete DSMZ Media List |
| Summary and <br />additional information : | Type strain. Taxonomy/description (2944, 2955). Plasmids (2957). Produces catechol-2,3-dioxygenase (2949), pyrazon dioxygenase (2948), dihydrodiols from phenylalanine (2951), 2-keto-4-hydroxy valeric acid (2950). Utilizes antipyrin (analgetic) (2947), chloridazon (2944), trans-cinnamic acid (2956). Composition of lipopolysaccharide (2952). Rhodanese activity (2953). Serological studies (2954). (Medium 363 (for reactivation, incubate lyophilised cells in liquid medium for up to 14 days) or medium 464 (diluted 1:3), 28°C). |
| For detailed information : | BacDive - The Bacterial Diversity Metadatabase |
| Literature : | 2944, 2945, 2946, 2947, 2948, 2949, 2950, 2951, 2952, 2953, 2954, 2955, 2956, 2957 |
| Risk group : | 1 (classification according to German TRBA) |
| Other cultures : | All DSMZ cultures of the species |